Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

380

HTML

3561

Tables (1-5)

205

Sum=4146

Jun 1, 2004 (publication date) through Sep 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Jun 1, 2004; 10(11): 1675-1677
Published online Jun 1, 2004. doi: 10.3748/wjg.v10.i11.1675

Table 4 The content of the 3 markers in the different positions of pancreatic cancer (mean ± SD, × 10³U/L)

Position of pancreatic cancer	No. of cases	TSGF	CA242	CA19-9
Head	64	88.5 ± 9.0^b	106.4 ± 12.6^b	653.7 ± 217.8
Body	18	78.2 ± 6.7	82.5 ± 10.4	633.9 ± 192.4
Tail	10	77.1 ± 5.7	81.6 ± 8.2	659.4 ± 211.0
Whole	4	74.5 ± 3.1	83.0 ± 9.5	615.3 ± 187.1

^bP < 0.001 vs body, tail and whole of pancreatic cancer.

Citation: Jiang JT, Wu CP, Deng HF, Lu MY, Wu J, Zhang HY, Sun WH, Ji M. Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer. World J Gastroenterol 2004; 10(11): 1675-1677
URL: https://www.wjgnet.com/1007-9327/full/v10/i11/1675.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i11.1675